-The Times of India   The Supreme Court on Tuesday agreed that the government had reasons to doubt its verdict laying down auction as the only way of allocating natural resources, in what is seen as an indication of a significant judicial rethink.  "On cancellation of spectrum licences allotted without following a transparent system, there is no doubt about its correctness. But if one reads the judgment to mean that auction must be...

-The Telegraph Ranchi: Jharkhand High Court today adjourned a hearing on the Nagri land acquisition controversy till Monday but asked the state to begin a dialogue with villagers who have disrupted construction of campuses of three national academic institutes. A division bench comprising Chief Justice Prakash Tatia and Justice Jaya Roy allowed the adjournment since advocate-general Anil Sinha was away in New Delhi, but asked the state government to work out a...

-The Telegraph The Supreme Court today asked Gujarat to submit a list, if any, of religious structures damaged in the 2002 riots as the state dug in its heels and declared its intention not to pay for the repair of these structures. A two-judge bench, comprising Justices K.S. Radhakrishnan and Dipak Mishra, adjourned the matter for further hearing on July 30 but not before it declared its intention to examine whether a...

-The Economic Times It's not just the drug regulator, where a parliamentary panel has alleged corruption, failing in its job. Drug regulation across entities that dot this broad landscape is in poor health and ineffective. In May, when a Parliamentary panel, during a routine examination of healthcare regulatory bodies, alleged corruption in the approval of new drugs, it was merely pointing out one symptom. Such symptoms pervade the entire drug regulation landscape,...

-The Indian Express India may not be a testing hub for Big Pharma. But informed consent must be non-negotiable Figures released by the World Health Organisation, which show that 10 Indian subjects of clinical field trials die every week, have rekindled concerns that this country has become a testing hub for Big Pharma. Ironically, the same figures deflate this persistent fear, revealing that only 1.5 per cent of global trials have been...